Skip to main content
. 2001 Aug 21;1:8. doi: 10.1186/1472-6963-1-8

Table 3.

Predictors of Influenza Complications and Hospitalziations

Presence During Interval of Care

Hospitalization (N = 103) Any Complication (N = 1,545)


OR* 95% Cl OR* 95% Cl
Sex (Female vs. Male) 1.02 0.67–1.56 1.00 0.89–1.12
Age
  <5 0.75 0.33–1.70 1.55 1.26–1.91
  5–14 0.45 0.19–1.10 1.08 0.89–1.32
  15–24 0.28 0.06–1.26 1.02 0.79–1.31
  25–34 0.83 0.33–2.07 0.99 0.78–1.26
  35–44 1.00 n/a 1.00
  45–54 1.22 0.59–2.52 0.85 0.67–1.08
  55–64 1.75 0.87–3.52 1.04 0.80–1.35
  65+ 1.93 0.82–4.56 1.54 1.06–2.24
Prior/Concurrent
 Prior Immunization 2.17 1.06–4.43 1.01 0.70–1.45
 Recent Comp/Comorbidity 3.17 1.96–5.13 1.47 1.27–1.70
 Concurrent Amant/ Rimant 0.60 0.18–2.00 1.22 0.91–1.63
 Prior Influenza Episode 0.32 0.09–1.07 0.85 0.66–1.09
Quintile of 3-Month Preceding Health Care Cost
 1:$0 1.00 1.00
 2: >$0–$86 0.38 0.22–1.22 0.92 0.75–1.12
 3:$87–$199 0.44 0.15–1.24 0.86 0.70–1.04
 4: $200–452 0.84 0.36–1.97 1.21 1.00–1.47
 5:$453+ 1.71 0.77–3.84 1.56 1.28–1.91
Medication Use and Prevalent Comorbid Conditions
 Chronic Corticosteroid Use 2.00 0.66–6.02 1.84 0.83–4.07
 Malignancy 3.67 1.82–7.44 2.38 1.44–3.93
 Chronic Heart Disease 3.16 1.66–6.00 1.76 1.19–2.61
 Chronic Lung Disease 1.29 0.81–2.05 1.15 1.00–1.34
 Diabetes 2.19 1.08–4.47 1.74 1.16–2.61

* Adjusted using logistic regression.

HHS Vulnerability Disclosure